Navigation Links
Cardiovascular Disorders Drug Development Pipeline Review 2017: 1,200 Pipeline Products within the CVD Therapy Area - Research and Markets
Date:4/10/2017

DUBLIN, Apr. 10, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Cardiovascular Disorders Drug Development Pipeline Review, 2017" report to their offering.

The report provides comprehensive information on the pipeline development landscape for Hypertension, Dyslipidemia, Venous thromboembolism and Heart failure, from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

There are over 1,200 pipeline products within the CVD therapy area. Over 50% of these products are small molecules however there is also diversification with regards to molecule types within the pipeline. In addition, the molecular targets in the pipeline are considerably diverse with a high frequency of products acting on targets related to lipid metabolism and those which act on elements of the coagulation cascade.

Among those pipeline drugs expected for imminent release to market there is a mixture of first-in-class products, typically anti-dyslipidemia drugs aiming to provide alternatives to statin therapy, and drugs belonging to currently popular classes such as PCSK9 inhibitors and direct factor Xa inhibitors.

Key Topics Covered:

1. Research Report Guidance

2. Executive Summary

3. Introduction

4. Cardiovascular Disorders Report Coverage

5. Therapeutics Development

6. Therapeutics under Development by Companies

7. Therapeutics under Investigation by Universities/Institutes

8. Pipeline Products Glance

9. Products under Development by Companies

10. Products under Investigation by Universities/Institutes

11. Companies Involved in Therapeutics Development

12. Therapeutics Assessment

13. Discontinued Products

14. Product Development Milestones

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/834p96/cardiovascular

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cardiovascular-disorders-drug-development-pipeline-review-2017-1200-pipeline-products-within-the-cvd-therapy-area---research-and-markets-300437192.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
2. World $114 Billion Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - Forecasts to 2022 - Research and Markets
3. Cardiovascular Systems, Inc. Secures $40 Million Line of Credit from Silicon Valley Bank
4. Akcea Initiates Phase 2 Study of AKCEA-APO(a)-L Rx in Patients with High Lp(a) and Cardiovascular Disease
5. The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases
6. Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System
7. Cardiac Holter Monitor Market to Reach US$518.9 Million by 2024: Rising Cases of Cardiovascular Diseases due to Sedentary Lifestyles Augment Demand, Observes TMR
8. Global Markets for Emerging Medical Device Technologies - Cardiovascular, Orthopedic, Neurology, Diabetes & In Vitro Diagnostics Markets - Research and Markets
9. Digital X-Ray System Market - Forecasts from 2016 to 2021 - Growing Incidents of Cardiovascular, Orthopedic & Dental Disorders Around the Globe - Research and Markets
10. True Health Chief Academic Officer and Cardiovascular Disease Expert to Lecture Before Miami Beach Symposium
11. New Supplement Based on Nobel Prize-Winning Research Boosts Nitric Oxide for Cardiovascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and which He does not. Yisrayl says with so many titles and names for ... but he says with a little Scripture, backed with a lot of research, the truth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
Breaking Medicine News(10 mins):